Are they really lost? "true" status and reasons for treatment discontinuation among HIV infected patients on antiretroviral therapy considered lost to follow up in Urban Malawi.
INTRODUCTION: Patients who are lost to follow-up (LTFU) while on antiretroviral therapy (ART) pose challenges to the long-term success of ART programs. We describe the extent to which patients considered LTFU are misclassified as true disengagement from care when they are still alive on ART and expl...
Main Authors: | , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3784425?pdf=render |
_version_ | 1819263852141871104 |
---|---|
author | Hannock Tweya Caryl Feldacker Janne Estill Andreas Jahn Wingston Ng'ambi Anne Ben-Smith Olivia Keiser Mphatso Bokosi Matthias Egger Colin Speight Joe Gumulira Sam Phiri |
author_facet | Hannock Tweya Caryl Feldacker Janne Estill Andreas Jahn Wingston Ng'ambi Anne Ben-Smith Olivia Keiser Mphatso Bokosi Matthias Egger Colin Speight Joe Gumulira Sam Phiri |
author_sort | Hannock Tweya |
collection | DOAJ |
description | INTRODUCTION: Patients who are lost to follow-up (LTFU) while on antiretroviral therapy (ART) pose challenges to the long-term success of ART programs. We describe the extent to which patients considered LTFU are misclassified as true disengagement from care when they are still alive on ART and explain reasons for ART discontinuation using our active tracing program to further improve ART retention programs and policies. METHODS: We identified adult ART patients who missed clinic appointment by more than 3 weeks between January 2006 and December 2010, assuming that such patients would miss their doses of antiretroviral drugs. Patients considered LTFU who consented during ART registration were traced by phone or home visits; true ART status after tracing was documented. Reasons for ART discontinuation were also recorded for those who stopped ART. RESULTS: Of the 4,560 suspected LTFU cases, 1,384 (30%) could not be traced. Of the 3,176 successfully traced patients, 952 (30%) were dead and 2,224 (70%) were alive, of which 2,183 (99.5%) started ART according to phone-based self-reports or physical verification during in-person interviews. Of those who started ART, 957 (44%) stopped ART and 1,226 (56%) reported still taking ART at the time of interview by sourcing drugs from another clinic, using alternative ART sources or making brief ART interruptions. Among 940 cases with reasons for ART discontinuations, failure to remember (17%), too weak/sick (12%), travel (46%), and lack of transport to the clinic (16%) were frequently cited; reasons differed by gender. CONCLUSION: The LTFU category comprises sizeable proportions of patients still taking ART that may potentially bias retention estimates and misdirect resources at the clinic and national levels if not properly accounted for. Clinics should consider further decentralization efforts, increasing drug allocations for frequent travels, and improving communication on patient transfers between clinics to increase retention and adherence. |
first_indexed | 2024-12-23T20:20:10Z |
format | Article |
id | doaj.art-fa230b36efbc47e1993bc7dc4e810b8a |
institution | Directory Open Access Journal |
issn | 1932-6203 |
language | English |
last_indexed | 2024-12-23T20:20:10Z |
publishDate | 2013-01-01 |
publisher | Public Library of Science (PLoS) |
record_format | Article |
series | PLoS ONE |
spelling | doaj.art-fa230b36efbc47e1993bc7dc4e810b8a2022-12-21T17:32:34ZengPublic Library of Science (PLoS)PLoS ONE1932-62032013-01-0189e7576110.1371/journal.pone.0075761Are they really lost? "true" status and reasons for treatment discontinuation among HIV infected patients on antiretroviral therapy considered lost to follow up in Urban Malawi.Hannock TweyaCaryl FeldackerJanne EstillAndreas JahnWingston Ng'ambiAnne Ben-SmithOlivia KeiserMphatso BokosiMatthias EggerColin SpeightJoe GumuliraSam PhiriINTRODUCTION: Patients who are lost to follow-up (LTFU) while on antiretroviral therapy (ART) pose challenges to the long-term success of ART programs. We describe the extent to which patients considered LTFU are misclassified as true disengagement from care when they are still alive on ART and explain reasons for ART discontinuation using our active tracing program to further improve ART retention programs and policies. METHODS: We identified adult ART patients who missed clinic appointment by more than 3 weeks between January 2006 and December 2010, assuming that such patients would miss their doses of antiretroviral drugs. Patients considered LTFU who consented during ART registration were traced by phone or home visits; true ART status after tracing was documented. Reasons for ART discontinuation were also recorded for those who stopped ART. RESULTS: Of the 4,560 suspected LTFU cases, 1,384 (30%) could not be traced. Of the 3,176 successfully traced patients, 952 (30%) were dead and 2,224 (70%) were alive, of which 2,183 (99.5%) started ART according to phone-based self-reports or physical verification during in-person interviews. Of those who started ART, 957 (44%) stopped ART and 1,226 (56%) reported still taking ART at the time of interview by sourcing drugs from another clinic, using alternative ART sources or making brief ART interruptions. Among 940 cases with reasons for ART discontinuations, failure to remember (17%), too weak/sick (12%), travel (46%), and lack of transport to the clinic (16%) were frequently cited; reasons differed by gender. CONCLUSION: The LTFU category comprises sizeable proportions of patients still taking ART that may potentially bias retention estimates and misdirect resources at the clinic and national levels if not properly accounted for. Clinics should consider further decentralization efforts, increasing drug allocations for frequent travels, and improving communication on patient transfers between clinics to increase retention and adherence.http://europepmc.org/articles/PMC3784425?pdf=render |
spellingShingle | Hannock Tweya Caryl Feldacker Janne Estill Andreas Jahn Wingston Ng'ambi Anne Ben-Smith Olivia Keiser Mphatso Bokosi Matthias Egger Colin Speight Joe Gumulira Sam Phiri Are they really lost? "true" status and reasons for treatment discontinuation among HIV infected patients on antiretroviral therapy considered lost to follow up in Urban Malawi. PLoS ONE |
title | Are they really lost? "true" status and reasons for treatment discontinuation among HIV infected patients on antiretroviral therapy considered lost to follow up in Urban Malawi. |
title_full | Are they really lost? "true" status and reasons for treatment discontinuation among HIV infected patients on antiretroviral therapy considered lost to follow up in Urban Malawi. |
title_fullStr | Are they really lost? "true" status and reasons for treatment discontinuation among HIV infected patients on antiretroviral therapy considered lost to follow up in Urban Malawi. |
title_full_unstemmed | Are they really lost? "true" status and reasons for treatment discontinuation among HIV infected patients on antiretroviral therapy considered lost to follow up in Urban Malawi. |
title_short | Are they really lost? "true" status and reasons for treatment discontinuation among HIV infected patients on antiretroviral therapy considered lost to follow up in Urban Malawi. |
title_sort | are they really lost true status and reasons for treatment discontinuation among hiv infected patients on antiretroviral therapy considered lost to follow up in urban malawi |
url | http://europepmc.org/articles/PMC3784425?pdf=render |
work_keys_str_mv | AT hannocktweya aretheyreallylosttruestatusandreasonsfortreatmentdiscontinuationamonghivinfectedpatientsonantiretroviraltherapyconsideredlosttofollowupinurbanmalawi AT carylfeldacker aretheyreallylosttruestatusandreasonsfortreatmentdiscontinuationamonghivinfectedpatientsonantiretroviraltherapyconsideredlosttofollowupinurbanmalawi AT janneestill aretheyreallylosttruestatusandreasonsfortreatmentdiscontinuationamonghivinfectedpatientsonantiretroviraltherapyconsideredlosttofollowupinurbanmalawi AT andreasjahn aretheyreallylosttruestatusandreasonsfortreatmentdiscontinuationamonghivinfectedpatientsonantiretroviraltherapyconsideredlosttofollowupinurbanmalawi AT wingstonngambi aretheyreallylosttruestatusandreasonsfortreatmentdiscontinuationamonghivinfectedpatientsonantiretroviraltherapyconsideredlosttofollowupinurbanmalawi AT annebensmith aretheyreallylosttruestatusandreasonsfortreatmentdiscontinuationamonghivinfectedpatientsonantiretroviraltherapyconsideredlosttofollowupinurbanmalawi AT oliviakeiser aretheyreallylosttruestatusandreasonsfortreatmentdiscontinuationamonghivinfectedpatientsonantiretroviraltherapyconsideredlosttofollowupinurbanmalawi AT mphatsobokosi aretheyreallylosttruestatusandreasonsfortreatmentdiscontinuationamonghivinfectedpatientsonantiretroviraltherapyconsideredlosttofollowupinurbanmalawi AT matthiasegger aretheyreallylosttruestatusandreasonsfortreatmentdiscontinuationamonghivinfectedpatientsonantiretroviraltherapyconsideredlosttofollowupinurbanmalawi AT colinspeight aretheyreallylosttruestatusandreasonsfortreatmentdiscontinuationamonghivinfectedpatientsonantiretroviraltherapyconsideredlosttofollowupinurbanmalawi AT joegumulira aretheyreallylosttruestatusandreasonsfortreatmentdiscontinuationamonghivinfectedpatientsonantiretroviraltherapyconsideredlosttofollowupinurbanmalawi AT samphiri aretheyreallylosttruestatusandreasonsfortreatmentdiscontinuationamonghivinfectedpatientsonantiretroviraltherapyconsideredlosttofollowupinurbanmalawi |